Analysis of fluconazole effect on Candida albicans viability during extended incubations

References

• Anaissie E, Bodey GP, Kantarjian H. Azole antifungal agents. Clin Infect Dis 1992; 14(Suppl. 1)S161–S169
   PubMedGoogle Scholar
• Hughes CE, Beggs WH. Action of fluconazole (UK-49,858) in relation to other systemic antifungal azoles. J Antimicrob Chemother 1987; 19: 171–174
   PubMed Web of Science ®Google Scholar
• Sheehan DJ, Espinel-Ingroff A, Moore LS, Webb KCD. Antifungal susceptibility testing of yeasts-a brief overview. Clin Infect Dis 1993; 17(Suppl. 2)S494–S500
   PubMed Web of Science ®Google Scholar
• Sohnle PG, Hahn BL, Erdmann MD. Effect of fluconazole on viability of Candida albicans over extended periods of time. Antimicrob Agents Chemother 1996; 40: 2622–2625
   PubMed Web of Science ®Google Scholar
• Anaissie E, Bodey G, Kantarjian H. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am J Med 1991; 91: 142–150
   PubMed Web of Science ®Google Scholar
• Brass C, Galgiani JN, Campbell SC, Stevens DA. Therapy of disseminated or pulmonary coccidioidomycosis with ketoconazole. Rev Infect Dis 1980; 2: 656–660
   PubMedGoogle Scholar
• Dismukes WE, Bradsher RW, Cloud GC, Kauffman CA, Chapman SW, George RB, Stevens DA, Girard WM, Saag MS, Bowles-Patton C, the NIAID Mycoses Study Group. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med 1992; 93: 489–497
   PubMed Web of Science ®Google Scholar
• Graybill Lundberg D, Jr, Donovan W, Levine HB, Rodriguez MD, Drutz DJ. Treatment of coccidioidomycosis with ketoconazole-clinical and laboratory studies of 18 patients. Rev Infect Dis 1980; 2: 661–673
   PubMedGoogle Scholar
• Kauffman CA, Bradley SE, Ross SC, Weber DR. Hepatosplenic candidiasis-successful treatment with fluconazole. Am J Med 1991; 91: 137–141
   PubMed Web of Science ®Google Scholar
• Durack DT, Beeson PB. Experimental bacterial endocarditis. II. Survival of bacteria in endocardial vegetations. Br J Pathol 1972; 53: 50–53
   PubMedGoogle Scholar
• Sohnle PG, Hahn BL. Inhibition of pseudohyphal growth as a neutrophil-mediated host defense mechanism against experimental deep Candida albicans infections in mice. J Lab Clin Med 1993; 121: 235–243
   PubMed Web of Science ®Google Scholar
• Anaissie EJ, Karyotakis NC, Hachem R, Dignani RC, Rex JH, Paetznick V. Correlation between in vitro and in vivo activity of antifungal agents against Candida species. J Infect Dis 1994; 170: 384–389
   PubMed Web of Science ®Google Scholar
• Galgiani JN. Susceptibility of Candida albicans and other yeasts to fluconazole-relation between in vitro and in vivo studies. Rev Infect Dis 1990; 12(Suppl. 3)S272–S275
   PubMedGoogle Scholar
• Troke PF, Andrews RJ, Pye GW, Richardson K. Fluconazole and other azoles-translation of in vitro activity to in vivo and clinical efficacy. Rev Infect Dis 1990; 12(Suppl. 3)S276–S280
   PubMedGoogle Scholar
• National Committee on Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; tentative standard. NCCLS, Wayne, PA 1995, NCCLS document M27-T
   Google Scholar
• Gujral S, Brummer E, Stevens DA. Role of extended culture time on synergy of fluconazole and human monocyte-derived macrophages in clearing Candida albicans. J Infect Dis 1996; 174: 888–890
   PubMed Web of Science ®Google Scholar
• Isaacson DM, Tolman EL, Tobia AJ, Rosenthale ME, McGuire JL, Van denBossche H, Janssen PAJ. Selective inhibition of 14α-desmethyl sterol synthesis in Candida albicans by terconazole, a new triazole antimycotic. J Antimicrob Chemother 1988; 21: 333–343
   PubMed Web of Science ®Google Scholar
• Van den Bossche H, Willemsens G, Cools W, Lauwers WFJ, Le Jeune L. Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans. Chem Biol Interact 1978; 21: 59–78
   PubMed Web of Science ®Google Scholar
• Van den Bossche H. Biochemical effects of miconazole on fungi. I. Effects on the uptake and/or utilization of purines, pyrimidines, nucleosides, amino acids and glucose by Candida albicans. Biochem Pharmacol 1974; 23: 887–899
   PubMed Web of Science ®Google Scholar